^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    BIRC5 expression

    i
    Entrez ID:
    332
    Related biomarkers:
    Expression
    Mutation
    Apply
    DPX-Survivac and Checkpoint Inhibitor in DLBCL (SPiReL) (NCT03349450)
    Phase 2
    Sunnybrook Health Sciences Centre
    Completed
    Last update posted :
    11/02/2023
    Initiation :
    03/13/2018
    Primary completion :
    10/31/2021
    Completion :
    07/18/2023
    BIRC5
    |
    BIRC5 expression
    |
    Keytruda (pembrolizumab) • cyclophosphamide • maveropepimut-S (MVP-S) • cyclophosphamide intravenous
    Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery (NCT06015269)
    Phase 1
    Shanghai Cell Therapy Group Co.,Ltd
    Recruiting
    Last update posted :
    08/29/2023
    Initiation :
    08/01/2023
    Primary completion :
    07/01/2025
    Completion :
    07/01/2025
    TP53
    |
    TP53 expression • BIRC5 expression
    Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT) (NCT02851056)
    Phase 1
    H. Lee Moffitt Cancer Center and Research Insti...
    Completed
    Last update posted :
    11/11/2022
    Initiation :
    09/27/2016
    Primary completion :
    07/16/2018
    Completion :
    08/09/2018
    BIRC5
    |
    BIRC5 expression
    Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma (NCT04873180)
    Phase N/A
    Sohag University
    Completed
    Last update posted :
    05/07/2021
    Initiation :
    01/01/2020
    Primary completion :
    06/30/2020
    Completion :
    12/30/2020
    BIRC5
    |
    BIRC5 expression • BIRC5 overexpression
    Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma (NCT02123381)
    Phase 2
    Sichuan Cancer Hospital and Research Institute
    Unknown status
    Last update posted :
    03/17/2020
    Initiation :
    04/01/2014
    Primary completion :
    07/01/2020
    Completion :
    07/01/2020
    TP53 • BIRC5
    |
    TP53 expression • BIRC5 expression
    |
    Erbitux (cetuximab)
    A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00620321)
    Phase 2
    Eli Lilly and Company
    Completed
    Last update posted :
    09/09/2019
    Initiation :
    03/01/2008
    Primary completion :
    01/01/2010
    Completion :
    01/01/2010
    BIRC5
    |
    BIRC5 expression
    |
    cytarabine • idarubicin hydrochloride • gataparsen (LY2181308)
    Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients (NCT00129376)
    Phase 2
    Spanish Breast Cancer Research Group
    Completed
    Last update posted :
    07/05/2019
    Initiation :
    02/01/2003
    Primary completion :
    07/01/2005
    Completion :
    02/01/2010
    BIRC5
    |
    BIRC5 expression • BIRC5 overexpression • CDKN1B expression • TOP2A expression
    |
    docetaxel • doxorubicin hydrochloride • cyclophosphamide • cyclophosphamide intravenous
    Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma (NCT01764477)
    Phase 1
    Prism Pharma Co., Ltd.
    Completed
    Last update posted :
    08/17/2017
    Initiation :
    04/01/2013
    Primary completion :
    10/01/2015
    Completion :
    10/01/2015
    BIRC5 • MMP7
    |
    BIRC5 expression
    |
    gemcitabine • 5-fluorouracil • oxaliplatin • irinotecan • leucovorin calcium • foscenvivint (PRI724)
    Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer (PRIMIER) (NCT02413853)
    Phase 2
    University of Southern California
    Withdrawn
    Last update posted :
    04/17/2017
    Initiation :
    11/01/2015
    Primary completion :
    11/01/2017
    Completion :
    11/01/2018
    BRAF • BIRC5
    |
    BIRC5 expression
    |
    Avastin (bevacizumab) • 5-fluorouracil • oxaliplatin • leucovorin calcium • foscenvivint (PRI724)
    Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma (NCT01250470)
    Phase 1
    Roswell Park Cancer Institute
    Completed
    Last update posted :
    02/27/2017
    Initiation :
    09/05/2012
    Primary completion :
    05/29/2014
    Completion :
    05/29/2014
    IFNG
    |
    BIRC5 expression
    |
    SurVaxM (SVN53-67/M57-KLH peptide vaccine) • Leukine (sargramostim)
    Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy (NCT00990587)
    Phase 1
    University Health Network, Toronto
    Completed
    Last update posted :
    06/22/2015
    Initiation :
    10/01/2009
    Primary completion :
    05/01/2013
    BIRC5
    |
    BIRC5 expression